Intertek Melbourn
Pharmaceutical Manufacturing • 
Royston, England, United Kingdom • 101-200 Employees
Company overview
| Headquarters | Intertek Melbourn, Saxon Way, Melbourn, Cambridge, Herts SG8 6DN, GB |
| Phone number | +441763261648 |
| Website | |
| NAICS | 3254 |
| Keywords | Product Development, Formulation, Formulation Development, Method Validation, Accelerated Feasibility Studies, Analytical Support, Inhaled Product Testing, Method Development, Qc And Finished Product Testing, Raw Material Testing, Stability Studies And Storage, Dissolution Testing, Biologics Formulation, Pharmaceutical Analytical Services, Cmc Development Support, Ich Stability Storage, Clinical Trial Gmp Manufacture, Drug Delivery Development, Inhalation Product Analysis And Testing, Inhaled Medicine Product Characterisation, Inhaled Vaccine Delivery, Mdrs, Nasal Drug Products, Nebulised Drug Delivery, Pharmaceutical Qc Testing, Repurposing Drugs For Oindp Delivery, Inhaled Medicine Development, In Vitro Bioequivalence Testing, Aerodynamic Particle / Droplet Size Distribution, Clinical & Finished Product Release Testing, Comparator Studies, Delivered Dose Uniformity, Device Compatibility Studies, Device Verification Testing, Drug Repurposing For Oindp Administration, Dry Powder Inhaler Development, Ivbe Studies, In Vitro Bioequivalence (Ivbe) Studies, Inhaled And Nasal Biologic Drug Development, Intranasal Drug Development, Laser Particle And Droplet Sizing, Mdrs Particle Studies, Particle Size Or Droplet Size, Patient In-Use / Misuse Studies, Pharmaceutical Stability Testing, Photostability Studies, Powder And Particle Characterization, Product Characterization Studies, Realistic Flow Profiles, Soft Mist Inhaler Development |
| Founded | 1989 |
| Employees | 101-200 |
| Socials |
Key Contacts at Intertek Melbourn
Stacey Crane
Associate Business Development Director
Teresa Iley
Director Of Pharmaceutical Development And Manufacture
Mark Parry
Senior Scientific Director
Intertek Melbourn Email Formats
Intertek Melbourn uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@melbournscientific.com), used 63.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@melbournscientific.com | 63.6% |
{first initial}.{last name} | j.doe@melbournscientific.com | 36.4% |
About Intertek Melbourn
A leading provider of pharmaceutical analysis and formulation support with 30+ years of experience in inhaled product development and Good Manufacturing Practice (GMP) compliant analytical testing and stability storage services. We have a reputation for providing outstanding and responsive customer service. Previously known as Melbourn Scientific Ltd, the laboratory, based near Cambridge UK, was acquired by Intertek in 2013. We opened a second facility in 2015 and another in 2019 leading to further expansion which has doubled our laboratory footprint. We have specialist skills and experience in analytical testing and formulation for inhaled and intranasal products as well as all other dosage forms for healthcare products. Clients include major pharmaceutical companies, drug delivery innovators, consultants and virtual companies. We have invested continually in the latest equipment and provides a range of services; pre-formulation and formulation, analytical support, method development and validation; stability studies and storage and accelerated feasibility studies. The laboratory is inspected and approved by the UK Medicines & Healthcare Products Regulatory Agency (MHRA) for GMP compliance. The Laboratory has also been inspected by the US Food and Drug Administration (FDA) against GMP as part of clients’ pre-approval inspections. Pharmaceutical Analytical Services Early Stage Pre-formulation support Formulation Development Orally Inhaled Product Development Inhalation Product Analysis And Testing Nasal Drug Product Development Analytical Method Development Method Validation Stability Storage and Testing Dissolution Testing Particle and Drop Characterization and Sizing Product Characterization Chemicals, Manufacturing and Controls (CMC) Support Clinical Trial GMP Manufacture QC Testing
Intertek Melbourn revenue & valuation
| Annual revenue | $8,726,610 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $28,000,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
Intertek Melbourn has 39 employees across 5 departments.
Departments
Number of employees
Funding Data
Intertek Melbourn has never raised funding before.
United States
Australia
Frequently asked questions
4.8
40,000 users
